@daz999999999：
$Genprex, Inc.(GNPX)$ GNPX (Genprex) forecasts show mixed signals, with some analysts projecting potential upside with a ~ $7.50 target despite current weakness, while others highlight significant risks like cash burn and reliance on clinical trial success, with fair value estimates suggesting the stock is overvalued or facing a "going concern" risk, indicating high volatility and uncertainty, especially given ongoing clinical trial progress. Analyst Ratings & Price Targets Strong Buy/Buy: Some analysts rate it a "Strong Buy," with one 12-month target around $7.50 - $7.88, seeing potential upside from current levels, according to MarketBeat and Fintel, sources 1, 2, 8. Sell/Hold: Other analyses lean negative due to financial health conce